Liraglutide Injection — FDA Drug Shortage

Current — Novo Nordisk, Inc.

The FDA lists a drug shortage record for Liraglutide Injection (injection) from Novo Nordisk, Inc. with status Current. The shortage was first posted on Jul 18, 2023.

Shortage details

Status
Current
Company
Novo Nordisk, Inc.
Package NDC
0480-3667-22
Dosage Form
Injection
Presentation
Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22)
Initial Posting
Jul 18, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.